Research programme: HIV integrase inhibitors - AvexaAlternative Names: AVX 15567
Latest Information Update: 28 Apr 2014
At a glance
- Originator Avexa
- Class Small molecules
- Mechanism of Action HIV integrase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical HIV infections